ASP Isotopes Inc. (ASPI)
NASDAQ: ASPI · Real-Time Price · USD
4.185
-0.545 (-11.52%)
At close: Mar 28, 2025, 4:00 PM
4.190
+0.005 (0.12%)
After-hours: Mar 28, 2025, 7:15 PM EDT
Company Description
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes.
It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28.
The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
ASP Isotopes Inc.
Country | United States |
Founded | 2021 |
IPO Date | Nov 10, 2022 |
Industry | Chemicals |
Sector | Materials |
Employees | 76 |
CEO | Paul Mann |
Contact Details
Address: 1101 Pennsylvania Avenue NW, Suite 300 Washington, District of Columbia 20004 United States | |
Phone | 202 756 2245 |
Website | aspisotopes.com |
Stock Details
Ticker Symbol | ASPI |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $4.00 |
CIK Code | 0001921865 |
CUSIP Number | 00218A105 |
ISIN Number | US00218A1051 |
Employer ID | 87-2618235 |
SIC Code | 2890 |
Key Executives
Name | Position |
---|---|
Dr. Gerdus Kemp M.D., Ph.D. | Medical Director and Chief Executive Officer of Pet Labs |
Paul Elliot Mann C.F.A. | President, Chief Executive Officer and Executive Chairman |
Robert Ainscow | Chief Operating Officer |
Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. | Chief Technology Officer and Director |
Heather Kiessling | Chief Financial Officer |
William Eden M.B.E. | Global Head of Human Resources and Director UK Nuclear Operations |
Hendrik T. van Wyk | Head of Engineering |
Dr. Xandra van Heerden Ph.D. | Head of Research and Development |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 27, 2025 | 8-K | Current Report |
Feb 26, 2025 | 8-K | Current Report |
Feb 18, 2025 | SCHEDULE 13G/A | Filing |
Feb 18, 2025 | SCHEDULE 13G/A | Filing |
Feb 14, 2025 | SCHEDULE 13G | Filing |
Feb 12, 2025 | SCHEDULE 13G/A | Filing |
Feb 4, 2025 | SCHEDULE 13G | Filing |
Jan 13, 2025 | 8-K | Current Report |
Dec 16, 2024 | 8-K | Current Report |
Dec 13, 2024 | 8-K | Current Report |